Chiloscyllium plagiosum isolate BGI_BamShark_2017 chromosome 36, ASM401019v2, whole genome shotgun sequence.
Chiloscyllium plagiosum (whitespotted bambooshark)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Orectolobiformes; Hemiscylliidae; Chiloscyllium.
REFSEQ INFORMATION: The reference sequence is identical to\nCM012991.1.\nAssembly name: ASM401019v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the BGI on 2019/01/10. The\noriginal whole-genome shotgun project has the accession\nQPFF00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: BGI\nAssembly Method :: platanus v. 1.2.4; 3ddna v. 170123\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 280.0x\nSequencing Technology :: BGIseq-500\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Chiloscyllium plagiosum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DIS3 like exosome 3'-5' exoribonuclease, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
DIS3 like exosome 3'-5' exoribonuclease, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
DIS3 like exosome 3'-5' exoribonuclease, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
mitogen-activated protein kinase kinase 1
dual specificity mitogen-activated protein kinase kinase 1
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00093
COORDINATES: nucleotide motif:Rfam:12.0:RF00138
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
lactase-like protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
lactase-like protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
small nuclear RNA activating complex, polypeptide 5
snRNA-activating protein complex subunit 5
ankyrin repeat domain-containing protein 34C
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122540876, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC122540876, transcript variant X1
uncharacterized LOC122540876, transcript variant X3
Ras protein specific guanine nucleotide releasing factor 1, transcript variant X1
Ras protein specific guanine nucleotide releasing factor 1, transcript variant X2
ras-specific guanine nucleotide-releasing factor 1 isoform X1
ras-specific guanine nucleotide-releasing factor 1 isoform X2
BLM RecQ like helicase, transcript variant X2
BLM RecQ like helicase, transcript variant X1
BLM RecQ like helicase, transcript variant X3
Bloom syndrome protein homolog isoform X1
Bloom syndrome protein homolog isoform X2
BLM RecQ like helicase, transcript variant X4
Bloom syndrome protein homolog isoform X3
FERM domain-containing protein 5, transcript variant X2
FERM domain-containing protein 5, transcript variant X1
FERM domain-containing protein 5, transcript variant X3
FERM domain-containing protein 5, transcript variant X4
FERM domain-containing protein 5, transcript variant X5
FERM domain-containing protein 5 isoform X1
FERM domain-containing protein 5 isoform X3
FERM domain-containing protein 5 isoform X4
FERM domain-containing protein 5 isoform X2
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2b, transcript variant X5
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2b, transcript variant X4
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2b, transcript variant X3
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2b, transcript variant X2
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
U6 snRNA-associated Sm-like protein LSm5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56% coverage of the annotated genomic feature by RNAseq alignments
eukaryotic translation initiation factor 3, subunit Jb
eukaryotic translation initiation factor 3 subunit J-B
SPG11 vesicle trafficking associated, spatacsin, transcript variant X1
SPG11 vesicle trafficking associated, spatacsin, transcript variant X5
SPG11 vesicle trafficking associated, spatacsin, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
SPG11 vesicle trafficking associated, spatacsin, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SPG11 vesicle trafficking associated, spatacsin, transcript variant X3
cytosolic iron-sulfur assembly component 2A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
A disintegrin and metalloproteinase with thrombospondin motifs 7-like, transcript variant X1
A disintegrin and metalloproteinase with thrombospondin motifs 7-like, transcript variant X2
A disintegrin and metalloproteinase with thrombospondin motifs 7-like isoform X1
A disintegrin and metalloproteinase with thrombospondin motifs 7-like isoform X2
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
mortality factor 4 like 1, transcript variant X2
mortality factor 4 like 1, transcript variant X1
mortality factor 4 like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
mortality factor 4-like protein 1 isoform X1
mortality factor 4-like protein 1 isoform X2
mortality factor 4-like protein 1 isoform X3
uveal autoantigen with coiled-coil domains and ankyrin repeats protein-like, transcript variant X2
uveal autoantigen with coiled-coil domains and ankyrin repeats protein-like, transcript variant X3
uveal autoantigen with coiled-coil domains and ankyrin repeats protein-like isoform X2
uveal autoantigen with coiled-coil domains and ankyrin repeats protein-like isoform X3
uveal autoantigen with coiled-coil domains and ankyrin repeats protein-like, transcript variant X1
uveal autoantigen with coiled-coil domains and ankyrin repeats protein-like, transcript variant X8
uveal autoantigen with coiled-coil domains and ankyrin repeats protein-like, transcript variant X6
uveal autoantigen with coiled-coil domains and ankyrin repeats protein-like, transcript variant X7
uveal autoantigen with coiled-coil domains and ankyrin repeats protein-like isoform X1
uveal autoantigen with coiled-coil domains and ankyrin repeats protein-like isoform X8
uveal autoantigen with coiled-coil domains and ankyrin repeats protein-like isoform X6
uveal autoantigen with coiled-coil domains and ankyrin repeats protein-like isoform X7
uveal autoantigen with coiled-coil domains and ankyrin repeats protein-like, transcript variant X4
uveal autoantigen with coiled-coil domains and ankyrin repeats protein-like, transcript variant X5
uveal autoantigen with coiled-coil domains and ankyrin repeats protein-like isoform X4
uveal autoantigen with coiled-coil domains and ankyrin repeats protein-like isoform X5
transducin-like enhancer protein 3, transcript variant X18
transducin-like enhancer protein 3, transcript variant X15
transducin-like enhancer protein 3, transcript variant X16
transducin-like enhancer protein 3, transcript variant X14
transducin-like enhancer protein 3, transcript variant X11
transducin-like enhancer protein 3, transcript variant X9
transducin-like enhancer protein 3, transcript variant X10
transducin-like enhancer protein 3, transcript variant X7
transducin-like enhancer protein 3, transcript variant X17
transducin-like enhancer protein 3, transcript variant X8
transducin-like enhancer protein 3, transcript variant X12
transducin-like enhancer protein 3, transcript variant X6
transducin-like enhancer protein 3, transcript variant X4
transducin-like enhancer protein 3, transcript variant X3
transducin-like enhancer protein 3, transcript variant X2
transducin-like enhancer protein 3, transcript variant X13
transducin-like enhancer protein 3, transcript variant X5
transducin-like enhancer protein 3, transcript variant X1
transducin-like enhancer protein 3 isoform X18
transducin-like enhancer protein 3 isoform X15
transducin-like enhancer protein 3 isoform X16
transducin-like enhancer protein 3 isoform X14
transducin-like enhancer protein 3 isoform X11
transducin-like enhancer protein 3 isoform X9
transducin-like enhancer protein 3 isoform X10
transducin-like enhancer protein 3 isoform X7
transducin-like enhancer protein 3 isoform X17
transducin-like enhancer protein 3 isoform X8
transducin-like enhancer protein 3 isoform X12
transducin-like enhancer protein 3 isoform X6
transducin-like enhancer protein 3 isoform X4
transducin-like enhancer protein 3 isoform X3
transducin-like enhancer protein 3 isoform X2
transducin-like enhancer protein 3 isoform X13
transducin-like enhancer protein 3 isoform X5
transducin-like enhancer protein 3 isoform X1
kinesin family member 23, transcript variant X10
kinesin family member 23, transcript variant X2
kinesin family member 23, transcript variant X1
kinesin family member 23, transcript variant X3
kinesin family member 23, transcript variant X5
kinesin family member 23, transcript variant X4
kinesin family member 23, transcript variant X6
kinesin family member 23, transcript variant X7
kinesin family member 23, transcript variant X9
kinesin family member 23, transcript variant X8
transfer RNA leucine (anticodon CAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
mothers against decapentaplegic homolog 6b
SMAD family member 3b, transcript variant X2
SMAD family member 3b, transcript variant X1
SMAD family member 3b, transcript variant X3
mothers against decapentaplegic homolog 3b isoform X1
mothers against decapentaplegic homolog 3b isoform X2
alpha and gamma adaptin binding protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
alpha and gamma adaptin binding protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
alpha- and gamma-adaptin-binding protein p34 isoform X2
alpha- and gamma-adaptin-binding protein p34 isoform X1
IQ motif containing H, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
IQ motif-containing protein H isoform X3
IQ motif containing H, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
IQ motif containing H, transcript variant X3
IQ motif containing H, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
IQ motif containing H, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
IQ motif-containing protein H isoform X2
IQ motif-containing protein H isoform X1
chromosome 36 C15orf61 homolog, transcript variant X1
chromosome 36 C15orf61 homolog, transcript variant X3
chromosome 36 C15orf61 homolog, transcript variant X2
uncharacterized protein C15orf61 homolog
mitogen-activated protein kinase kinase 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
mitogen-activated protein kinase kinase 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
mitogen-activated protein kinase kinase 5, transcript variant X3
mitogen-activated protein kinase kinase 5, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
mitogen-activated protein kinase kinase 5, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
dual specificity mitogen-activated protein kinase kinase 5 isoform X2
dual specificity mitogen-activated protein kinase kinase 5 isoform X1
dual specificity mitogen-activated protein kinase kinase 5 isoform X3
dual specificity mitogen-activated protein kinase kinase 5 isoform X4
uncharacterized LOC122540901, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC122540901, transcript variant X5
uncharacterized LOC122540901, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC122540901, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC122540901, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC122540901, transcript variant X2
SKI family transcriptional corepressor 1 homolog-B-like, transcript variant X1
SKI family transcriptional corepressor 1 homolog-B-like, transcript variant X4
SKI family transcriptional corepressor 1 homolog-B-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SKI family transcriptional corepressor 1 homolog-B-like, transcript variant X2
SKI family transcriptional corepressor 1 homolog-B-like, transcript variant X3
SKI family transcriptional corepressor 1 homolog-B-like isoform X1
SKI family transcriptional corepressor 1 homolog-B-like isoform X2
SKI family transcriptional corepressor 1 homolog-B-like isoform X3
uncharacterized LOC122540904, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC122540904, transcript variant X2
calmodulin-like protein 4, transcript variant X1
calmodulin-like protein 4, transcript variant X2
ceroid-lipofuscinosis neuronal protein 6 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122540812, transcript variant X2
uncharacterized LOC122540812, transcript variant X3
uncharacterized LOC122540812, transcript variant X1
uncharacterized protein LOC122540812 isoform X1
uncharacterized protein LOC122540812 isoform X2
NADPH oxidase, EF-hand calcium binding domain 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122540911, transcript variant X2
uncharacterized LOC122540911, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
D-glucuronyl C5-epimerase-like, transcript variant X2
D-glucuronyl C5-epimerase-like, transcript variant X5
D-glucuronyl C5-epimerase-like, transcript variant X4
D-glucuronyl C5-epimerase-like, transcript variant X1
D-glucuronyl C5-epimerase-like, transcript variant X3
D-glucuronyl C5-epimerase-like isoform X1
D-glucuronyl C5-epimerase-like, transcript variant X6
D-glucuronyl C5-epimerase-like isoform X2
membrane progestin receptor gamma-B-like, transcript variant X1
membrane progestin receptor gamma-B-like, transcript variant X2
membrane progestin receptor gamma-B-like isoform X1
membrane progestin receptor gamma-B-like isoform X2
transmembrane emp24 domain-containing protein 3-like
interferon-stimulated gene 20 kDa protein-like, transcript variant X2
interferon-stimulated gene 20 kDa protein-like, transcript variant X1
interferon-stimulated gene 20 kDa protein-like isoform X2
interferon-stimulated gene 20 kDa protein-like isoform X1
apoptosis-enhancing nuclease-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
apoptosis-enhancing nuclease-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
apoptosis-enhancing nuclease-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
apoptosis-enhancing nuclease-like, transcript variant X4
kelch-like protein 25, transcript variant X1
kelch-like protein 25, transcript variant X2
A-kinase anchor protein 13-like, transcript variant X7
A-kinase anchor protein 13-like, transcript variant X6
A-kinase anchor protein 13-like, transcript variant X4
A-kinase anchor protein 13-like, transcript variant X3
A-kinase anchor protein 13-like, transcript variant X5
A-kinase anchor protein 13-like, transcript variant X2
A-kinase anchor protein 13-like, transcript variant X1
A-kinase anchor protein 13-like, transcript variant X8
A-kinase anchor protein 13-like isoform X4
A-kinase anchor protein 13-like isoform X3
A-kinase anchor protein 13-like isoform X5
A-kinase anchor protein 13-like isoform X2
A-kinase anchor protein 13-like isoform X1
A-kinase anchor protein 13-like isoform X6
synaptic vesicle glycoprotein 2B-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
synaptic vesicle glycoprotein 2B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
synaptic vesicle glycoprotein 2B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
synaptic vesicle glycoprotein 2B-like, transcript variant X3
synaptic vesicle glycoprotein 2B-like, transcript variant X5
solute carrier organic anion transporter family member 3A1a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
solute carrier organic anion transporter family member 3A1
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
alpha-2,8-sialyltransferase 8B isoform X2
alpha-2,8-sialyltransferase 8B isoform X3
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
alpha-2,8-sialyltransferase 8B isoform X1
family with sequence similarity 174 member B
CTS telomere maintenance complex component 1
chromodomain helicase DNA binding protein 2, transcript variant X1
chromodomain helicase DNA binding protein 2, transcript variant X2
chromodomain-helicase-DNA-binding protein 2 isoform X1
chromodomain-helicase-DNA-binding protein 2 isoform X2
repulsive guidance molecule BMP co-receptor a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Ras-related and estrogen-regulated growth inhibitor-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 54% coverage of the annotated genomic feature by RNAseq alignments
WD repeat domain 93, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
WD repeat domain 93, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
WD repeat-containing protein 93 isoform X1
WD repeat-containing protein 93 isoform X2
gonadotropin releasing hormone receptor 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 73 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
gonadotropin releasing hormone receptor 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 73 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
gonadotropin releasing hormone receptor 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
aggrecan core protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
aggrecan core protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
aggrecan core protein-like, transcript variant X3
hyaluronan and proteoglycan link protein 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
hyaluronan and proteoglycan link protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
hyaluronan and proteoglycan link protein 3-like isoform X2
hyaluronan and proteoglycan link protein 3-like isoform X1
EGF-like repeat and discoidin I-like domain-containing protein 3 isoform X2
EGF-like repeat and discoidin I-like domain-containing protein 3 isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
monoacylglycerol lipase ABHD2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
monoacylglycerol lipase ABHD2-like, transcript variant X1
monoacylglycerol lipase ABHD2-like, transcript variant X2
monoacylglycerol lipase ABHD2-like isoform X1
monoacylglycerol lipase ABHD2-like isoform X2
TopBP1-interacting, checkpoint, and replication regulator, transcript variant X2
TopBP1-interacting, checkpoint, and replication regulator, transcript variant X3
TopBP1-interacting, checkpoint, and replication regulator, transcript variant X1
Rh family, C glycoprotein b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 111 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Rh family, C glycoprotein b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 111 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Rh family, C glycoprotein b, transcript variant X4
Rh family, C glycoprotein b, transcript variant X5
Rh family, C glycoprotein b, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 111 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Rh family, C glycoprotein b, transcript variant X1
uncharacterized LOC122540936, transcript variant X1
uncharacterized LOC122540936, transcript variant X3
uncharacterized LOC122540936, transcript variant X2
uncharacterized LOC122540936, transcript variant X4
uncharacterized LOC122540819, transcript variant X2
uncharacterized LOC122540819, transcript variant X3
uncharacterized LOC122540819, transcript variant X8
uncharacterized LOC122540819, transcript variant X6
uncharacterized LOC122540819, transcript variant X4
uncharacterized LOC122540819, transcript variant X5
uncharacterized LOC122540819, transcript variant X1
uncharacterized LOC122540819, transcript variant X9
uncharacterized LOC122540819, transcript variant X7
uncharacterized protein LOC122540819 isoform X1
uncharacterized protein LOC122540819 isoform X2
transfer RNA arginine (anticodon UCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
polymerase (DNA directed), gamma, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
polymerase (DNA directed), gamma, transcript variant X1
polymerase (DNA directed), gamma, transcript variant X5
polymerase (DNA directed), gamma, transcript variant X6
polymerase (DNA directed), gamma, transcript variant X7
polymerase (DNA directed), gamma, transcript variant X8
polymerase (DNA directed), gamma, transcript variant X4
polymerase (DNA directed), gamma, transcript variant X2
polymerase (DNA directed), gamma, transcript variant X3
DNA polymerase subunit gamma-1 isoform X1
DNA polymerase subunit gamma-1 isoform X3
DNA polymerase subunit gamma-1 isoform X4
DNA polymerase subunit gamma-1 isoform X5
DNA polymerase subunit gamma-1 isoform X6
DNA polymerase subunit gamma-1 isoform X2
DNA polymerase subunit gamma-1 isoform X7
FA complementation group I, transcript variant X3
FA complementation group I, transcript variant X1
FA complementation group I, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Fanconi anemia group I protein isoform X2
Fanconi anemia group I protein isoform X1
transfer RNA arginine (anticodon ACG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 104 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
UDP-glucuronosyltransferase 2A1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 116 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
UDP-glucuronosyltransferase 2A1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 116 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
UDP-glucuronosyltransferase 2A1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 116 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
UDP-glucuronosyltransferase 2A1-like, transcript variant X1
UDP-glucuronosyltransferase 2A1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 102 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
UDP-glucuronosyltransferase 2A1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 102 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 92 Proteins, and 28% coverage of the annotated genomic feature by RNAseq alignments
UDP-glucuronosyltransferase 2A1-like isoform X1
UDP-glucuronosyltransferase 2A1-like isoform X2
UDP-glucuronosyltransferase 2A1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 110 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 110 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 110 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 110 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
kinesin family member 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
UDP-glucuronosyltransferase 2A2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
UDP-glucuronosyltransferase 2A2-like, transcript variant X2
UDP-glucuronosyltransferase 2A2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC122540949 isoform X1
UDP-glucuronosyltransferase 2A2-like isoform X2
UDP-glucuronosyltransferase 2A2-like isoform X3
kinesin family member 7, transcript variant X1
uncharacterized LOC122540950, transcript variant X5
uncharacterized LOC122540950, transcript variant X2
uncharacterized LOC122540950, transcript variant X1
uncharacterized LOC122540950, transcript variant X4
uncharacterized LOC122540950, transcript variant X3
DET1 partner of COP1 E3 ubiquitin ligase, transcript variant X2
DET1 partner of COP1 E3 ubiquitin ligase, transcript variant X1
28S ribosomal protein S11, mitochondrial
mitochondrial ribosomal protein L46, transcript variant X1
mitochondrial ribosomal protein L46, transcript variant X2
39S ribosomal protein L46, mitochondrial isoform X1
39S ribosomal protein L46, mitochondrial isoform X2
uncharacterized LOC122540820, transcript variant X2
uncharacterized LOC122540820, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122540821, transcript variant X1
uncharacterized LOC122540821, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
gonadotropin-releasing hormone II receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
poly (ADP-ribose) polymerase family, member 16, transcript variant X3
protein mono-ADP-ribosyltransferase PARP16 isoform X3
poly (ADP-ribose) polymerase family, member 16, transcript variant X2
poly (ADP-ribose) polymerase family, member 16, transcript variant X1
protein mono-ADP-ribosyltransferase PARP16 isoform X2
protein mono-ADP-ribosyltransferase PARP16 isoform X1
uncharacterized LOC122540959, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122540959, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122540959, transcript variant X3
uncharacterized LOC122540959, transcript variant X2
uncharacterized protein LOC122540959 isoform X1
uncharacterized protein LOC122540959 isoform X2
immunoglobulin superfamily, DCC subclass, member 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
immunoglobulin superfamily DCC subclass member 3
immunoglobulin superfamily, DCC subclass, member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
immunoglobulin superfamily, DCC subclass, member 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
immunoglobulin superfamily, DCC subclass, member 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
immunoglobulin superfamily DCC subclass member 4 isoform X2
immunoglobulin superfamily DCC subclass member 4 isoform X1
immunoglobulin superfamily DCC subclass member 4 isoform X3
immunoglobulin superfamily, DCC subclass, member 4, transcript variant X8
immunoglobulin superfamily, DCC subclass, member 4, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
immunoglobulin superfamily, DCC subclass, member 4, transcript variant X9
immunoglobulin superfamily, DCC subclass, member 4, transcript variant X6
immunoglobulin superfamily DCC subclass member 4 isoform X5
immunoglobulin superfamily, DCC subclass, member 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
immunoglobulin superfamily, DCC subclass, member 4, transcript variant X4
immunoglobulin superfamily DCC subclass member 4 isoform X6
immunoglobulin superfamily DCC subclass member 4 isoform X4
immunoglobulin superfamily, DCC subclass, member 4, transcript variant X10
immunoglobulin superfamily DCC subclass member 4 isoform X7
dipeptidyl peptidase 8-like, transcript variant X3
dipeptidyl peptidase 8-like, transcript variant X1
dipeptidyl peptidase 8-like, transcript variant X2
dipeptidyl peptidase 8-like, transcript variant X4
dipeptidyl peptidase 8-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
solute carrier family 51 subunit beta, transcript variant X1
solute carrier family 51 subunit beta, transcript variant X2
solute carrier family 51 subunit beta, transcript variant X4
solute carrier family 51 subunit beta, transcript variant X3
solute carrier family 51 subunit beta, transcript variant X5
solute carrier family 51 subunit beta isoform X1
solute carrier family 51 subunit beta isoform X2
kelch repeat and BTB domain containing 13a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
kelch repeat and BTB domain-containing protein 13
ubiquitin associated protein 1-like b, transcript variant X2
ubiquitin associated protein 1-like b, transcript variant X1
ubiquitin-associated protein 1 isoform X1
ubiquitin-associated protein 1 isoform X2
caseinolytic mitochondrial matrix peptidase chaperone subunit Xa, transcript variant X2
caseinolytic mitochondrial matrix peptidase chaperone subunit Xa, transcript variant X1
caseinolytic mitochondrial matrix peptidase chaperone subunit Xa isoform X2
caseinolytic mitochondrial matrix peptidase chaperone subunit Xa isoform X1
myelin expression factor 2, transcript variant X3
myelin expression factor 2, transcript variant X2
myelin expression factor 2, transcript variant X1
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X3
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X2
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X4
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X5
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X11
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X6
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X1
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X8
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X7
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X9
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like, transcript variant X10
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like isoform X3
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like isoform X2
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like isoform X5
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like isoform X4
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like isoform X8
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like isoform X6
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like isoform X1
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D, like isoform X7
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 290 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 290 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
LysM, putative peptidoglycan-binding, domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
LysM, putative peptidoglycan-binding, domain containing 2, transcript variant X1
lysM and putative peptidoglycan-binding domain-containing protein 2 isoform X1
lysM and putative peptidoglycan-binding domain-containing protein 2 isoform X2
secretogranin III, transcript variant X2
secretogranin III, transcript variant X1
secretogranin III, transcript variant X3
adaptor related protein complex 4 subunit epsilon 1, transcript variant X1
AP-4 complex subunit epsilon-1 isoform X1
adaptor related protein complex 4 subunit epsilon 1, transcript variant X2
AP-4 complex subunit epsilon-1 isoform X2
tumor necrosis factor, alpha-induced protein 8-like 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
tumor necrosis factor alpha-induced protein 8-like protein 3
LEO1 homolog, Paf1/RNA polymerase II complex component
uncharacterized LOC122540984, transcript variant X2
uncharacterized LOC122540984, transcript variant X3
uncharacterized LOC122540984, transcript variant X1
guanine nucleotide-binding protein subunit beta-5, transcript variant X3
guanine nucleotide-binding protein subunit beta-5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
guanine nucleotide-binding protein subunit beta-5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
guanine nucleotide-binding protein subunit beta-5 isoform X1
guanine nucleotide-binding protein subunit beta-5 isoform X3
guanine nucleotide-binding protein subunit beta-5 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 214 member A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
family with sequence similarity 214 member A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
family with sequence similarity 214 member A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
family with sequence similarity 214 member A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
family with sequence similarity 214 member A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
family with sequence similarity 214 member A, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
family with sequence similarity 214 member A, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
one cut homeobox 1, transcript variant X2
one cut homeobox 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC122540992, transcript variant X3
uncharacterized LOC122540992, transcript variant X1
uncharacterized LOC122540992, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ATPase phospholipid transporting 8B4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ATPase phospholipid transporting 8B4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ATPase phospholipid transporting 8B4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ATPase phospholipid transporting 8B4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ATPase phospholipid transporting 8B4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
NAD(P) transhydrogenase, mitochondrial-like
DTW domain containing 1, transcript variant X1
DTW domain containing 1, transcript variant X2
tRNA-uridine aminocarboxypropyltransferase 1
protein FAM227B-like, transcript variant X2
protein FAM227B-like, transcript variant X1
fibroblast growth factor 7, transcript variant X1
fibroblast growth factor 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
COP9 signalosome subunit 2, transcript variant X1
COP9 signalosome subunit 2, transcript variant X2
COP9 signalosome subunit 2, transcript variant X3
COP9 signalosome subunit 2, transcript variant X4
COP9 signalosome subunit 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
COP9 signalosome complex subunit 2 isoform X1
COP9 signalosome complex subunit 2 isoform X2
COP9 signalosome complex subunit 2 isoform X3
COP9 signalosome complex subunit 2 isoform X4
COP9 signalosome complex subunit 2 isoform X5
SECIS binding protein 2-like, transcript variant X1
SECIS binding protein 2-like, transcript variant X2
SECIS binding protein 2-like, transcript variant X3
selenocysteine insertion sequence-binding protein 2-like isoform X1
selenocysteine insertion sequence-binding protein 2-like isoform X2
selenocysteine insertion sequence-binding protein 2-like isoform X3
regulator of G-protein signaling 7-binding protein-like
SHC-transforming protein 1-like, transcript variant X6
SHC-transforming protein 1-like, transcript variant X3
SHC-transforming protein 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
SHC-transforming protein 1-like, transcript variant X4
SHC-transforming protein 1-like, transcript variant X1
SHC-transforming protein 1-like, transcript variant X2
SHC-transforming protein 1-like isoform X1
SHC-transforming protein 1-like isoform X2
SHC-transforming protein 1-like isoform X3
SHC-transforming protein 1-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 41% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ring finger protein 111, transcript variant X3
ring finger protein 111, transcript variant X1
ring finger protein 111, transcript variant X2
E3 ubiquitin-protein ligase Arkadia isoform X2
E3 ubiquitin-protein ligase Arkadia isoform X1
SAFB-like, transcription modulator, transcript variant X1
SAFB-like, transcription modulator, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
SAFB-like, transcription modulator, transcript variant X2
SAFB-like transcription modulator isoform X1
SAFB-like transcription modulator isoform X2
SAFB-like transcription modulator isoform X3
MINDY lysine 48 deubiquitinase 2, transcript variant X2
MINDY lysine 48 deubiquitinase 2, transcript variant X1
ubiquitin carboxyl-terminal hydrolase MINDY-2 isoform X2
ubiquitin carboxyl-terminal hydrolase MINDY-2 isoform X1
MINDY lysine 48 deubiquitinase 2, transcript variant X3
MINDY lysine 48 deubiquitinase 2, transcript variant X4
disintegrin and metalloproteinase domain-containing protein 10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 107 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transcription factor 12, transcript variant X2
transcription factor 12, transcript variant X7
transcription factor 12, transcript variant X1
transcription factor 12, transcript variant X6
transcription factor 12, transcript variant X4
transcription factor 12, transcript variant X5
transcription factor 12, transcript variant X3
transcription factor 12, transcript variant X8
transcription factor 12, transcript variant X9
zinc finger protein 280D, transcript variant X3
zinc finger protein 280D, transcript variant X2
zinc finger protein 280D, transcript variant X1
zinc finger protein 280D, transcript variant X4
zinc finger protein 280D, transcript variant X5
meiosis-specific nuclear structural protein 1
testis expressed 9, transcript variant X1
testis expressed 9, transcript variant X3
testis expressed 9, transcript variant X2
DNA-binding protein RFX7-like, transcript variant X1
DNA-binding protein RFX7-like isoform X1
DNA-binding protein RFX7-like, transcript variant X2
DNA-binding protein RFX7-like isoform X2
NEDD4 E3 ubiquitin protein ligase a, transcript variant X3
NEDD4 E3 ubiquitin protein ligase a, transcript variant X4
E3 ubiquitin-protein ligase NEDD4a isoform X3
E3 ubiquitin-protein ligase NEDD4a isoform X4
NEDD4 E3 ubiquitin protein ligase a, transcript variant X1
NEDD4 E3 ubiquitin protein ligase a, transcript variant X2
E3 ubiquitin-protein ligase NEDD4a isoform X1
E3 ubiquitin-protein ligase NEDD4a isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC122541031, transcript variant X2
uncharacterized LOC122541031, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein LOC122541031 isoform X2
uncharacterized protein LOC122541031 isoform X1
cell cycle progression 1, transcript variant X8
cell cycle progression protein 1 isoform X8
cell cycle progression 1, transcript variant X1
cell cycle progression 1, transcript variant X6
cell cycle progression 1, transcript variant X4
cell cycle progression 1, transcript variant X3
cell cycle progression 1, transcript variant X5
cell cycle progression 1, transcript variant X7
cell cycle progression 1, transcript variant X2
cell cycle progression protein 1 isoform X1
cell cycle progression protein 1 isoform X6
cell cycle progression protein 1 isoform X4
cell cycle progression protein 1 isoform X3
cell cycle progression protein 1 isoform X5
cell cycle progression protein 1 isoform X7
cell cycle progression protein 1 isoform X2
RAB27A, member RAS oncogene family, transcript variant X6
RAB27A, member RAS oncogene family, transcript variant X7
RAB27A, member RAS oncogene family, transcript variant X3
RAB27A, member RAS oncogene family, transcript variant X5
RAB27A, member RAS oncogene family, transcript variant X2
RAB27A, member RAS oncogene family, transcript variant X1
RAB27A, member RAS oncogene family, transcript variant X4
probable ribosome biogenesis protein RLP24
protein unc-13 homolog C, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein unc-13 homolog C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein unc-13 homolog C, transcript variant X4
protein unc-13 homolog C, transcript variant X1
protein unc-13 homolog C, transcript variant X2
protein disulfide isomerase family A, member 3
cation channel sperm-associated protein 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cation channel sperm-associated protein 2-like, transcript variant X2
cation channel sperm-associated protein 2-like, transcript variant X5
cation channel sperm-associated protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
cation channel sperm-associated protein 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cation channel sperm-associated protein 2-like isoform X1
cation channel sperm-associated protein 2-like isoform X3
cation channel sperm-associated protein 2-like isoform X4
cation channel sperm-associated protein 2-like isoform X2
leucine rich repeat containing 28, transcript variant X4
leucine rich repeat containing 28, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
leucine rich repeat containing 28, transcript variant X1
leucine rich repeat containing 28, transcript variant X3
leucine-rich repeat-containing protein 28 isoform X1
leucine-rich repeat-containing protein 28 isoform X2
myocyte enhancer factor 2aa, transcript variant X8
myocyte enhancer factor 2aa, transcript variant X2
myocyte enhancer factor 2aa, transcript variant X6
myocyte enhancer factor 2aa, transcript variant X4
myocyte enhancer factor 2aa, transcript variant X7
myocyte enhancer factor 2aa, transcript variant X1
myocyte enhancer factor 2aa, transcript variant X5
myocyte enhancer factor 2aa, transcript variant X3
LysM, putative peptidoglycan-binding, domain containing 4, transcript variant X2
LysM, putative peptidoglycan-binding, domain containing 4, transcript variant X1
lysM and putative peptidoglycan-binding domain-containing protein 4
arrestin domain-containing protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 8% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122541046, transcript variant X2
uncharacterized LOC122541046, transcript variant X1
COUP transcription factor 2, transcript variant X3
COUP transcription factor 2, transcript variant X4
COUP transcription factor 2, transcript variant X1
COUP transcription factor 2, transcript variant X2
multiple C2 and transmembrane domain-containing protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
multiple C2 and transmembrane domain-containing protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
multiple C2 and transmembrane domain-containing protein 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
multiple C2 and transmembrane domain-containing protein 2-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
multiple C2 and transmembrane domain-containing protein 2-like, transcript variant X3
multiple C2 and transmembrane domain-containing protein 2-like, transcript variant X5
multiple C2 and transmembrane domain-containing protein 2-like isoform X1
multiple C2 and transmembrane domain-containing protein 2-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
multiple C2 and transmembrane domain-containing protein 2-like isoform X2
multiple C2 and transmembrane domain-containing protein 2-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
multiple C2 and transmembrane domain-containing protein 2-like, transcript variant X9
multiple C2 and transmembrane domain-containing protein 2-like isoform X3
multiple C2 and transmembrane domain-containing protein 2-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
multiple C2 and transmembrane domain-containing protein 2-like isoform X5
multiple C2 and transmembrane domain-containing protein 2-like, transcript variant X10
multiple C2 and transmembrane domain-containing protein 2-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 32% coverage of the annotated genomic feature by RNAseq alignments
RNA polymerase II elongation factor ELL, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
RNA polymerase II elongation factor ELL, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
RNA polymerase II elongation factor ELL, transcript variant X5
RNA polymerase II elongation factor ELL, transcript variant X4
RNA polymerase II elongation factor ELL, transcript variant X3
RNA polymerase II elongation factor ELL isoform X2
RNA polymerase II elongation factor ELL isoform X1
RNA polymerase II elongation factor ELL isoform X5
RNA polymerase II elongation factor ELL isoform X4
RNA polymerase II elongation factor ELL isoform X3
RNA polymerase II elongation factor ELL, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
RNA polymerase II elongation factor ELL isoform X6
FKBP prolyl isomerase 16, transcript variant X2
FKBP prolyl isomerase 16, transcript variant X1
zona pellucida sperm-binding protein 3-like, transcript variant X1
zona pellucida sperm-binding protein 3-like isoform X1
zona pellucida sperm-binding protein 3-like, transcript variant X2
zona pellucida sperm-binding protein 3-like isoform X2
zona pellucida sperm-binding protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zona pellucida sperm-binding protein 3-like, transcript variant X4
zona pellucida sperm-binding protein 3-like isoform X4
zona pellucida sperm-binding protein 3-like, transcript variant X3
zona pellucida sperm-binding protein 3-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ras and EF-hand domain-containing protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ba
uncharacterized LOC122541065, transcript variant X2
uncharacterized LOC122541065, transcript variant X1
uncharacterized LOC122541065, transcript variant X3
uncharacterized LOC122541064, transcript variant X2
uncharacterized LOC122541064, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
zinc finger protein 710a, transcript variant X1
zinc finger protein 710a, transcript variant X2
isocitrate dehydrogenase [NADP], mitochondrial
uncharacterized LOC122541069, transcript variant X3
uncharacterized LOC122541069, transcript variant X2
uncharacterized LOC122541069, transcript variant X1
transmembrane 6 superfamily member 1-like, transcript variant X3
transmembrane 6 superfamily member 1-like, transcript variant X1
transmembrane 6 superfamily member 1-like, transcript variant X2
transmembrane 6 superfamily member 1-like isoform X1
transmembrane 6 superfamily member 1-like isoform X3
transmembrane 6 superfamily member 1-like isoform X2
hepatoma-derived growth factor-related protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
SH3-domain GRB2-like 3a, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
SH3-domain GRB2-like 3a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
SH3-domain GRB2-like 3a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
SH3-domain GRB2-like 3a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
SH3-domain GRB2-like 3a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
SH3-domain GRB2-like 3a, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC791214 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC791214 homolog, transcript variant X3
uncharacterized protein LOC791214 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein LOC791214 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
E3 ubiquitin-protein ligase MARCHF3 isoform X2
E3 ubiquitin-protein ligase MARCHF3 isoform X3
E3 ubiquitin-protein ligase MARCHF3 isoform X1
lamin-L(III)-like, transcript variant X2
lamin-L(III)-like, transcript variant X1
lamin-L(III)-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
elongation factor like GTPase 1, transcript variant X1
elongation factor like GTPase 1, transcript variant X2
elongation factor-like GTPase 1 isoform X1
elongation factor-like GTPase 1 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
transmembrane channel-like protein 3, transcript variant X1
transmembrane channel-like protein 3, transcript variant X2
transmembrane channel-like protein 3, transcript variant X3
transmembrane channel-like protein 3 isoform X1
transmembrane channel-like protein 3 isoform X2
transmembrane channel-like protein 3 isoform X3
StAR-related lipid transfer (START) domain containing 5, transcript variant X2
StAR-related lipid transfer (START) domain containing 5, transcript variant X1
stAR-related lipid transfer protein 5 isoform X2
stAR-related lipid transfer protein 5 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
cell migration-inducing and hyaluronan-binding protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
abhydrolase domain containing 17C, depalmitoylase
alpha/beta hydrolase domain-containing protein 17C
uncharacterized LOC122540863, transcript variant X2
uncharacterized LOC122540863, transcript variant X1
aryl-hydrocarbon receptor nuclear translocator 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
aryl-hydrocarbon receptor nuclear translocator 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
aryl-hydrocarbon receptor nuclear translocator 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
aryl-hydrocarbon receptor nuclear translocator 2, transcript variant X1
aryl-hydrocarbon receptor nuclear translocator 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
aryl hydrocarbon receptor nuclear translocator 2 isoform X2
aryl hydrocarbon receptor nuclear translocator 2 isoform X1
aryl hydrocarbon receptor nuclear translocator 2 isoform X3
cortexin domain-containing 1, transcript variant X2
cortexin domain-containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
cortexin domain-containing 1, transcript variant X3
cortexin domain-containing 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
fumarylacetoacetate hydrolase (fumarylacetoacetase)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
zinc finger, AN1-type domain 6, transcript variant X6
zinc finger, AN1-type domain 6, transcript variant X5
zinc finger, AN1-type domain 6, transcript variant X2
zinc finger, AN1-type domain 6, transcript variant X7
zinc finger, AN1-type domain 6, transcript variant X1
zinc finger, AN1-type domain 6, transcript variant X8
zinc finger, AN1-type domain 6, transcript variant X3
zinc finger, AN1-type domain 6, transcript variant X4
AN1-type zinc finger protein 6 isoform X3
AN1-type zinc finger protein 6 isoform X1
AN1-type zinc finger protein 6 isoform X2
zinc finger, AN1-type domain 6, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
zinc finger, AN1-type domain 6, transcript variant X9
AN1-type zinc finger protein 6 isoform X4
AN1-type zinc finger protein 6 isoform X5
5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase), transcript variant X1
5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase) isoform X1
5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase), transcript variant X2
5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase) isoform X2
complement C1q tumor necrosis factor-related protein 3-like
membrane integral NOTCH2 associated receptor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
major intrinsically disordered Notch2-binding receptor 1 isoform X1
membrane integral NOTCH2 associated receptor 1, transcript variant X2
major intrinsically disordered Notch2-binding receptor 1 isoform X2
ADAM metallopeptidase with thrombospondin type 1 motif, 17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
A disintegrin and metalloproteinase with thrombospondin motifs 17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ankyrin repeat and SOCS box containing 7, transcript variant X1
ankyrin repeat and SOCS box containing 7, transcript variant X10
ankyrin repeat and SOCS box containing 7, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ankyrin repeat and SOCS box containing 7, transcript variant X4
ankyrin repeat and SOCS box containing 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ankyrin repeat and SOCS box containing 7, transcript variant X6
ankyrin repeat and SOCS box containing 7, transcript variant X8
ankyrin repeat and SOCS box containing 7, transcript variant X2
ankyrin repeat and SOCS box containing 7, transcript variant X7
ankyrin repeat and SOCS box containing 7, transcript variant X9
ankyrin repeat and SOCS box protein 7 isoform X2
ankyrin repeat and SOCS box protein 7 isoform X1
ankyrin repeat and SOCS box protein 7 isoform X3
aldehyde dehydrogenase 1 family, member A3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 71 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
aldehyde dehydrogenase family 1 member A3 isoform X2
aldehyde dehydrogenase 1 family, member A3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 71 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
aldehyde dehydrogenase 1 family, member A3, transcript variant X3
aldehyde dehydrogenase family 1 member A3 isoform X1
aldehyde dehydrogenase family 1 member A3 isoform X3
uncharacterized LOC122540865, transcript variant X2
uncharacterized LOC122540865, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
leucine-rich repeat serine/threonine-protein kinase 1
chondroitin sulfate synthase 1, transcript variant X2
chondroitin sulfate synthase 1, transcript variant X1
chondroitin sulfate synthase 1 isoform X2
chondroitin sulfate synthase 1 isoform X1
small nuclear ribonucleoprotein polypeptide A'
pleckstrin homology domain-containing family O member 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
calcium-binding mitochondrial carrier protein SCaMC-3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium-binding mitochondrial carrier protein SCaMC-3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
calcium-binding mitochondrial carrier protein SCaMC-3-like, transcript variant X3
calcium-binding mitochondrial carrier protein SCaMC-3-like, transcript variant X4
calcium-binding mitochondrial carrier protein SCaMC-3-like isoform X1
calcium-binding mitochondrial carrier protein SCaMC-1-like isoform X2
calcium-binding mitochondrial carrier protein SCaMC-1-like isoform X3
ankyrin repeat and death domain containing 1A, transcript variant X7
ankyrin repeat and death domain containing 1A, transcript variant X6
ankyrin repeat and death domain containing 1A, transcript variant X2
ankyrin repeat and death domain containing 1A, transcript variant X3
ankyrin repeat and death domain containing 1A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ankyrin repeat and death domain containing 1A, transcript variant X5
ankyrin repeat and death domain containing 1A, transcript variant X4
ankyrin repeat and death domain containing 1A, transcript variant X8
ankyrin repeat and death domain-containing protein 1A isoform X1
ankyrin repeat and death domain-containing protein 1A isoform X6
ankyrin repeat and death domain-containing protein 1A isoform X5
ankyrin repeat and death domain-containing protein 1A isoform X4
ankyrin repeat and death domain-containing protein 1A isoform X3
ankyrin repeat and death domain-containing protein 1A isoform X7
ankyrin repeat and death domain-containing protein 1A isoform X2
ankyrin repeat and death domain containing 1A, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ankyrin repeat and death domain-containing protein 1A isoform X8
gastrula zinc finger protein xLCGF3.1-like, transcript variant X2
gastrula zinc finger protein xLCGF3.1-like, transcript variant X3
gastrula zinc finger protein xLCGF3.1-like, transcript variant X1
gastrula zinc finger protein xLCGF3.1-like, transcript variant X4
gastrula zinc finger protein xLCGF3.1-like isoform X4
zinc transporter ZIP1-like, transcript variant X1
zinc transporter ZIP1-like, transcript variant X2
SPG21 abhydrolase domain containing, maspardin, transcript variant X8
SPG21 abhydrolase domain containing, maspardin, transcript variant X1
SPG21 abhydrolase domain containing, maspardin, transcript variant X7
SPG21 abhydrolase domain containing, maspardin, transcript variant X4
SPG21 abhydrolase domain containing, maspardin, transcript variant X6
SPG21 abhydrolase domain containing, maspardin, transcript variant X3
SPG21 abhydrolase domain containing, maspardin, transcript variant X5
SPG21 abhydrolase domain containing, maspardin, transcript variant X2
C-X-C chemokine receptor type 5, transcript variant X2
C-X-C chemokine receptor type 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
C-X-C chemokine receptor type 5, transcript variant X3
C-X-C chemokine receptor type 5, transcript variant X5
C-X-C chemokine receptor type 5, transcript variant X4
C-X-C chemokine receptor type 5 isoform X2
C-X-C chemokine receptor type 5 isoform X1
C-X-C chemokine receptor type 5 isoform X3
probable ATP-dependent RNA helicase ddx6, transcript variant X2
probable ATP-dependent RNA helicase ddx6, transcript variant X1
probable ATP-dependent RNA helicase ddx6
trehalase (brush-border membrane glycoprotein), transcript variant X1
trehalase (brush-border membrane glycoprotein), transcript variant X6
trehalase (brush-border membrane glycoprotein), transcript variant X2
trehalase (brush-border membrane glycoprotein), transcript variant X3
trehalase (brush-border membrane glycoprotein), transcript variant X4
trehalase (brush-border membrane glycoprotein), transcript variant X7
trehalase (brush-border membrane glycoprotein), transcript variant X5
VPS11 core subunit of CORVET and HOPS complexes
vacuolar protein sorting-associated protein 11 homolog
intraflagellar transport 46 homolog (Chlamydomonas), transcript variant X1
intraflagellar transport 46 homolog (Chlamydomonas), transcript variant X2
intraflagellar transport protein 46 homolog isoform X1
intraflagellar transport protein 46 homolog isoform X2
hepatic and glial cell adhesion molecule a
coiled-coil domain containing 153, transcript variant X1
coiled-coil domain containing 153, transcript variant X2
coiled-coil domain-containing protein 153 isoform X1
coiled-coil domain-containing protein 153 isoform X2
Cbl proto-oncogene, E3 ubiquitin protein ligase, transcript variant X3
Cbl proto-oncogene, E3 ubiquitin protein ligase, transcript variant X1
Cbl proto-oncogene, E3 ubiquitin protein ligase, transcript variant X2
E3 ubiquitin-protein ligase CBL isoform X1
E3 ubiquitin-protein ligase CBL isoform X2
E3 ubiquitin-protein ligase CBL isoform X3
constitutive coactivator of PPAR-gamma-like protein 2
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
cell surface glycoprotein MUC18-like, transcript variant X2
cell surface glycoprotein MUC18-like, transcript variant X1
cell surface glycoprotein MUC18-like, transcript variant X3
cell surface glycoprotein MUC18-like, transcript variant X4
cell surface glycoprotein MUC18-like isoform X3
cell surface glycoprotein MUC18-like isoform X4
cell surface glycoprotein MUC18-like isoform X2
cell surface glycoprotein MUC18-like isoform X1
uncharacterized LOC122541128, transcript variant X1
uncharacterized LOC122541128, transcript variant X2
uncharacterized LOC122541128, transcript variant X3
C1q and TNF related 5, transcript variant X1
C1q and TNF related 5, transcript variant X2
complement C1q tumor necrosis factor-related protein 5
membrane frizzled-related protein-like, transcript variant X5
membrane frizzled-related protein-like, transcript variant X2
membrane frizzled-related protein-like, transcript variant X1
membrane frizzled-related protein-like, transcript variant X3
membrane frizzled-related protein-like, transcript variant X4
membrane frizzled-related protein-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
membrane frizzled-related protein-like isoform X2
membrane frizzled-related protein-like isoform X1
membrane frizzled-related protein-like isoform X4
membrane frizzled-related protein-like isoform X3
membrane frizzled-related protein-like isoform X5
ubiquitin specific peptidase 2a, transcript variant X2
ubiquitin specific peptidase 2a, transcript variant X4
ubiquitin specific peptidase 2a, transcript variant X3
ubiquitin specific peptidase 2a, transcript variant X1
ubiquitin specific peptidase 2a, transcript variant X5
ubiquitin carboxyl-terminal hydrolase 2a isoform X1
ubiquitin carboxyl-terminal hydrolase 2a isoform X2
ubiquitin carboxyl-terminal hydrolase 2a isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
HOATZ cilia and flagella associated protein, transcript variant X5
HOATZ cilia and flagella associated protein, transcript variant X6
HOATZ cilia and flagella associated protein, transcript variant X4
HOATZ cilia and flagella associated protein, transcript variant X1
HOATZ cilia and flagella associated protein, transcript variant X7
cilia- and flagella-associated protein HOATZ isoform X4
cilia- and flagella-associated protein HOATZ isoform X1
cilia- and flagella-associated protein HOATZ isoform X6
cilia- and flagella-associated protein HOATZ isoform X5
HOATZ cilia and flagella associated protein, transcript variant X2
cilia- and flagella-associated protein HOATZ isoform X2
HOATZ cilia and flagella associated protein, transcript variant X3
cilia- and flagella-associated protein HOATZ isoform X3
B-cell translocation gene 4, transcript variant X6
B-cell translocation gene 4, transcript variant X1
B-cell translocation gene 4, transcript variant X4
B-cell translocation gene 4, transcript variant X5
B-cell translocation gene 4, transcript variant X2
B-cell translocation gene 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns